The Mpox outbreak, formerly known as monkeypox, has escalated into a global health crisis. WHO is considering declaring it a Public Health Emergency of International Concern.
Mpox is a viral disease caused by the monkeypox virus (MPXV) from the Orthopoxvirus genus. It was first identified in 1958, with human cases emerging in 1970 in the DRC.
Mpox spreads through direct contact with infectious lesions or respiratory droplets. It can also be transmitted from animals to humans through bites, scratches, or handling infected animals.
Symptoms include fever, rash, sore throat, and muscle aches. The rash starts as flat sores, developing into blisters that eventually crust over and heal.
Mpox can cause severe complications, especially in children, pregnant individuals, and those with weakened immune systems. Complications include bacterial infections, pneumonia, and even death.
WHO is fast-tracking Mpox vaccines through the Emergency Use Listing (EUL) process. Vaccination is crucial for high-risk groups to control the spread of the virus.
A coordinated global effort is essential to manage the Mpox outbreak. Continued collaboration and financial support are vital to protect public health worldwide.